(AU) AngloGold Ashanti - Overview
Stock: Gold, Silver, Sulphuric Acid
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.95% |
| Yield on Cost 5y | 12.27% |
| Yield CAGR 5y | 47.05% |
| Payout Consistency | 69.5% |
| Payout Ratio | 58.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 53.8% |
| Relative Tail Risk | -4.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.47 |
| Alpha | 232.93 |
| Character TTM | |
|---|---|
| Beta | 0.386 |
| Beta Downside | 0.014 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.33% |
| CAGR/Max DD | 1.64 |
Description: AU AngloGold Ashanti February 05, 2026
AngloGold Ashanti plc (NYSE:AU) is a global gold mining firm with operations across Africa, Australia, and the Americas, focusing on gold extraction and by-products such as silver and sulphuric acid. Its flagship asset is the 100 % owned Geita mine in Tanzania’s Lake Victoria goldfields. The company, incorporated in 1944, is headquartered in Greenwood Village, Colorado.
In 2023 the company produced approximately 2.5 million ounces of gold, reporting a cash cost of $950 per ounce and an all-in sustaining cost of $1,150 per ounce-both metrics that remain competitive given the current average gold price of roughly $2,000 per ounce (2024). AngloGold’s reserve life index stands at about 8 years, supported by ongoing exploration programs that added 300,000 ounces of proven and probable reserves in the last twelve months.
Key sector drivers include persistent inflationary pressures that keep gold attractive as an inflation hedge, and central-bank buying that has risen 12 % year-over-year, reinforcing demand fundamentals. For a deeper, data-rich view of AngloGold’s valuation dynamics, consider exploring the detailed analyst framework on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 11.97 > 1.0 |
| NWC/Revenue: 32.45% < 20% (prev 16.55%; Δ 15.90% < -1%) |
| CFO/TA 0.25 > 3% & CFO 3.77b > Net Income 2.25b |
| Net Debt (-231.0m) to EBITDA (3.73b): -0.06 < 3 |
| Current Ratio: 2.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (506.8m) vs 12m ago 20.45% < -2% |
| Gross Margin: 46.71% > 18% (prev 0.26%; Δ 4645 % > 0.5%) |
| Asset Turnover: 72.56% > 50% (prev 70.78%; Δ 1.78% > 0%) |
| Interest Coverage Ratio: 11.38 > 6 (EBITDA TTM 3.73b / Interest Expense TTM 201.0m) |
Altman Z'' 5.63
| A: 0.19 (Total Current Assets 4.54b - Total Current Liabilities 1.76b) / Total Assets 14.84b |
| B: 0.48 (Retained Earnings 7.14b / Total Assets 14.84b) |
| C: 0.19 (EBIT TTM 2.29b / Avg Total Assets 11.82b) |
| D: 1.46 (Book Value of Equity 7.69b / Total Liabilities 5.28b) |
| Altman-Z'' Score: 5.63 = AAA |
Beneish M -3.16
| DSRI: 1.36 (Receivables 680.0m/363.0m, Revenue 8.57b/6.23b) |
| GMI: 0.55 (GM 46.71% / 25.83%) |
| AQI: 0.67 (AQ_t 0.11 / AQ_t-1 0.17) |
| SGI: 1.38 (Revenue 8.57b / 6.23b) |
| TATA: -0.10 (NI 2.25b - CFO 3.77b) / TA 14.84b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of AU shares?
Over the past week, the price has changed by +11.93%, over one month by +10.99%, over three months by +54.86% and over the past year by +246.68%.
Is AU a buy, sell or hold?
- StrongBuy: 1
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.1 | 7.9% |
| Analysts Target Price | 112.1 | 7.9% |
| ValueRay Target Price | 165.4 | 59.1% |
AU Fundamental Data Overview February 01, 2026
P/E Forward = 14.0252
P/S = 5.6662
P/B = 7.0264
Revenue TTM = 8.57b USD
EBIT TTM = 2.29b USD
EBITDA TTM = 3.73b USD
Long Term Debt = 2.02b USD (from longTermDebt, last quarter)
Short Term Debt = 164.0m USD (from shortTermDebt, last quarter)
Debt = 2.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -231.0m USD (from netDebt column, last quarter)
Enterprise Value = 48.36b USD (48.59b + Debt 2.31b - CCE 2.55b)
Interest Coverage Ratio = 11.38 (Ebit TTM 2.29b / Interest Expense TTM 201.0m)
EV/FCF = 19.30x (Enterprise Value 48.36b / FCF TTM 2.51b)
FCF Yield = 5.18% (FCF TTM 2.51b / Enterprise Value 48.36b)
FCF Margin = 29.22% (FCF TTM 2.51b / Revenue TTM 8.57b)
Net Margin = 26.25% (Net Income TTM 2.25b / Revenue TTM 8.57b)
Gross Margin = 46.71% ((Revenue TTM 8.57b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 49.32% (prev 48.96%)
Tobins Q-Ratio = 3.26 (Enterprise Value 48.36b / Total Assets 14.84b)
Interest Expense / Debt = 3.50% (Interest Expense 81.0m / Debt 2.31b)
Taxrate = 22.89% (242.0m / 1.06b)
NOPAT = 1.76b (EBIT 2.29b * (1 - 22.89%))
Current Ratio = 2.58 (Total Current Assets 4.54b / Total Current Liabilities 1.76b)
Debt / Equity = 0.30 (Debt 2.31b / totalStockholderEquity, last quarter 7.69b)
Debt / EBITDA = -0.06 (Net Debt -231.0m / EBITDA 3.73b)
Debt / FCF = -0.09 (Net Debt -231.0m / FCF TTM 2.51b)
Total Stockholder Equity = 7.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.05% (Net Income 2.25b / Total Assets 14.84b)
RoE = 31.58% (Net Income TTM 2.25b / Total Stockholder Equity 7.13b)
RoCE = 25.00% (EBIT 2.29b / Capital Employed (Equity 7.13b + L.T.Debt 2.02b))
RoIC = 19.16% (NOPAT 1.76b / Invested Capital 9.21b)
WACC = 7.13% (E(48.59b)/V(50.90b) * Re(7.34%) + D(2.31b)/V(50.90b) * Rd(3.50%) * (1-Tc(0.23)))
Discount Rate = 7.34% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 9.67%
[DCF Debug] Terminal Value 74.38% ; FCFF base≈1.68b ; Y1≈1.10b ; Y5≈502.2m
Fair Price DCF = 23.52 (EV 11.64b - Net Debt -231.0m = Equity 11.87b / Shares 504.9m; r=7.13% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 38.96 | EPS CAGR: -18.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 72.69 | Revenue CAGR: 25.48% | SUE: -0.19 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.96 | Chg30d=+0.950 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=8.86 | Chg30d=+0.687 | Revisions Net=+2 | Growth EPS=+60.7% | Growth Revenue=+35.0%